Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PRXL - Parexel International -- Ignore unavailable to you. Want to Upgrade?

To: Jeffrey D who wrote (32)	2/25/1999 10:06:00 AM
From: Platter	Read Replies (1) \| Respond to of 62

Given recent upgrade"(Reuters) - Salomon Smith Barney on Wednesday said it raised its rating on Parexel International Corp. to buy from outperform following the company's second quarter earnings report. -- said Q2 EPS of $0.21 was below Salomon's estimate of $0.22 a share but revenues of $87 million beat estimate of $83 million. -- lowered FY99 estimates to $0.93 a share from $0.96 and set a price target of $33 a share. -- shares of Parexel were $4.68 higher at $29 in afternoon trading on Nasdaq."...PRXL looks like a goog buy here!